Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 515 (1-2) , 57-63
- https://doi.org/10.1016/0006-8993(90)90576-w
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Transmitter‐Like Release of Endogenous 3,4‐Dihydroxyphenylalanine from Rat Striatal SlicesJournal of Neurochemistry, 1988
- Inhibition of the Tyrosine Hydroxylase System by MPTP, 1-Methyl-4-phenylpyridinium Ion (MPP+) and the Structurally Related Compounds in vitro and in vivoEuropean Neurology, 1987
- Early and late effects of systemically administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on tyrosine hydroxylase activity in vitro and on tyrosine hydroxylation in tissue slices of mouse striatumNeuroscience Letters, 1986
- 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathwayNature, 1986
- Neurochemical and Histochemical Characterization of Neurotoxic Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine on Brain Catecholamine Neurones in the MouseJournal of Neurochemistry, 1985
- Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heartLife Sciences, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Presynaptic mediation by α2-, β1- and β2-adrenoceptors of endogenous noradrenaline and dopamine release from slices of rat hypothalamusLife Sciences, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966